CFTR and cystic fibrosis: The 2019 spike in testing in Lab C may be ascribed to CF specialist clinics’ doctors requesting sequencing for patients who either lacked a paper/electronic copy of previous testing reports confirming their CF genetic diagnosis or for those patients with only one known pathogenic CFTR variant reported at the time of initial diagnosis when CFTR sequencing was unavailable.